Ty Cross, President and CEO, CLJI Worldwide LLC

Ty Cross, President and CEO, CLJI Worldwide LLC, working together with ACS in the area of Clinical Strategy & Evaluation, Clinical Project Management & Monitoring

"Before I met Annet Muetstege PhD of Applied Clinical Services on July 15, 2015, I was at a loss – we were in need of end to end clinical and consultative expertise for a first-of-its-kind human clinical trial to study our innovative new product.  I had no clear pathway forward from a study design standpoint, and limited time and resources to get it all done.  Annet and her amazing staff at ACS not only demonstrated significant knowledge and professionalism throughout all phases of the engagement, they also completed the project on time and under budget!  I can honestly say that ACS is the most responsive and client focused firm I’ve had the pleasure of working with.  Needless to say, I remain a loyal client."

Ton Pennings, Director of CEpartner4U

Ton Pennings, Director of CEpartner4U, working together with ACS in the area of Clinical Strategy & Evaluation, Clinical Project Management & Monitoring

"I came to learn Annet in 2015 during a regulatory project for an American client with a controversial substance based device. What I noticed was her experise, combined with practical experience plus the ability to present the complex requirements in a comprehensive manner. A combination you don’t see that often with regulatory specialists.
Ever since, I have appreciated her as skilled conversation partner, result oriented but with a keen eye voor other people's views, and where it comes to framing a project; also capable of thinking out of the box and to come with creative solutions. Personally, I appreciate Annet to be part of my network."

David Quijano, Manager Clinical Safety, Endologix, Inc

David Quijano, Manager Clinical Safety at Endologix, Inc, working together with ACS in the area of Clinical Project Management & Monitoring

"Annet has been an integral part of our EU operations. She continuously demonstrates her dedication with her responsiveness and communication with our in-house team, while ensuring she stays abreast of site activities. Her experience in contracting work has been invaluable and her readiness to take on further tasks and activities make her a clear leader."

Kees den Besten, VP Global Quality, Regulatory Affairs & Clinical Research at Hoya Surgical Optics

Kees den Besten, VP Global Quality, Regulatory Affairs & Clinical Research at Hoya Surgical Optics, working together with ACS in the area of Clinical Strategy & Evaluation, Clinical Project Management & Monitoring

"After many years our paths crossed again when I needed an interim person to manage our clinical programs and I found out Annet started her own company. Annet is very professional and keeps her commitments. She is unique in a sense that she large experience in setting up and managing medical device studies, which is essentially different from pharmaceutical studies. She is hands-on, gives good advice and also helped us out in setting up an overall clinical strategy. I will definitely involve her again if I need additional support in clinical matters."

Jan van de Mooren, Global Director Clinical Research at Danone/Nutricia

Jan van de Mooren, Global Director Clinical Research at Danone/Nutricia working together with ACS in the area of Clinical Project Management

"Annet has been working in my team as a senior Clinical Project Manager for 1 year, delivering high quality results in very complex projects, in a very professional way. She was able to easy adapt to our team and ways of working, demonstrating a solution driven mindset, highly dedicated to the employers goals. Top class quality!"

Raphael Tan, Business Owner at IMEC Consulting

Raphael Tan, Business Owner at IMEC Consulting, having worked together with ACS at Mölnlycke Health Care on Clinical Strategy and team development

"When I lead an overarching change management manoeuvre and created a Medical Clinical and Market Access cluster, I asked Annet Muetstege to lead a new team of Evidence Strategists. The challenge was to get scientists out of their comfort zone and liaise with various stakeholders to collect input in order to systematically build Evidence Strategy Plans for prioritized products and address evidence needs from a regulatory and commercial perspective.

Her approach of guiding the evidence strategists was a carefully chosen mix between a directive and coaching style which resonated very well with the team. She managed to have them create a communication infrastructure with internal and external stakeholders and complete a number of Plans that covered pre- and post-market studies with fit-for-purpose designs.

Aside from her industry experience and sound methodological judgement, her ability to quickly familiarise herself with the subject matter and company culture definitely contributed to the success of her intervention."